Pain is one of the most common reasons that adults seek medical care in the United States. It can lead to restrictions in mobility and daily activities, as well other medical conditions, like anxiety, depression and sleep disorders. Currently available analgesic medications are limited by low efficacy, high adverse effect rates, cost, and other factors.
Clearly, we need new approaches.
The endocannabinoid system (ECS) is intricately involved in the processing and modulation of pain signals, both in the peripheral and central nervous systems. CBD, THC, and other cannabinoids show promise as analgesic and anti-inflammatory agents in both animal and human studies.
In this webinar, Jamie Corroon, ND, will describe the role of the ECS in pain signal processing, and review the research on CBD in the context of analgesia and pain management.
SPONSORED BY CV Sciences
Dr. Jamie Corroon, ND, MPH, is the founder and Medical Director of the Center for Medical Cannabis Education, a clinic and educational resource center in Encinitas, CA. Dr. Corroon is a licensed Naturopathic Doctor, peer-reviewed clinical researcher, and industry consultant with a focus on medical Cannabis.
He earned his ND degree from Bastyr University in Seattle, a leader in naturopathic education and integrative medicine research. He subsequently completed two years of residency at the Bastyr Center for Natural Health, and is a former adjunct professor at Bastyr’s California campus in San Diego. In addition to his ND degree, Dr. Corroon also holds a Master’s in Public Health in Epidemiology from San Diego State University and a bachelor’s degree in Political Science and Business Administration from the University of Southern California. Dr. Corroon has completed certification programs from both the Society of Cannabis Clinicians and the American Academy of Cannabinoid Medicine. He is a member of both organizations, and serves on the Editorial and Research committees for the SCC.
